Company intelligence / Profile preview

G&G Biotechnology

Haifa, Northern District, Israelfinder.startupnationcentral.org ↗

Ownership: Private
Development stage: Other

Overview

G&G Biotechnology developed and commercialized the world’s first and only lightweight breast implant, B-Lite®, which uses a patented microsphere-enhanced silicone gel to reduce implant weight by up to 30% compared to traditional implants. The product has been used in thousands of patients globally, with clinical data indicating reduced post-treatment pain and downtime compared to standard silicone implants. The company was acquired via stock-swap merger by Polytech Health & Aesthetics in 2018, expanding global reach and manufacturing capabilities.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Polytech Health & Aesthetics (strategic alliance/manufacturing/quality assurance partner before full merger)AMSilk GmbH (related to Polytech, not G&G post-merger)

Beyond the preview

Go deeper on G&G Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on G&G Biotechnology.

Explore the full profile